Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/1530 stock hub

HKG/1530 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/1530is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

55.8B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/1530

In the news

Latest news · HKG/1530

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.3

P25 11.7P50 18.9P75 41.4

Trailing P/E5.8

P25 10.7P50 17.9P75 38.5

ROE37.5

P25 -14.7P50 2P75 9.4

ROIC65.9

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/1530 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

242

Groups with data

Currency

CNY

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	6,109
Employees Change	532%
Employees Change Percent	9.54
Enterprise value	HKD 40.5B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG8875G1029
Last refreshed	2026-05-10
Market cap	HKD 55.8B
Price	HKD 22.32
Price currency	HKD
Rev Per Employee	3,223,442.6x
Sector	Healthcare
Sic	2836
Symbol	hkg/1530
Website	https://www.3sbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	16.91%
EV Earnings	4.29x
EV/EBIT	3.51x
EV/EBITDA	3.34x
EV/FCF	3.93x
EV/Sales	2.06x
FCF yield	18.45%
Forward P/E	17.28x
P/B ratio	1.65x
P/E ratio	5.85x
P/S ratio	2.83x
PE Ratio10 Y	10.31x
PE Ratio3 Y	11.03x
PE Ratio5 Y	10.19x
PEG ratio	2.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	59.26%
EBITDA Margin	62.13%
FCF margin	52.31%
Gross margin	92.38%
Gross Profit	HKD 18.2B
Gross Profit Growth	111.02%
Gross Profit Growth Q	213.36%
Gross Profit Growth3 Y	31.21%
Gross Profit Growth5 Y	20.98%
Net Income	HKD 9.4B
Net Income Growth	305.78%
Net Income Growth Q	612.13%
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Net Income Growth3 Y	72.29%
Net Income Growth5 Y	34.47%
Pretax Margin	60.74%
Profit Margin	47.93%
Profit Per Employee	HKD 1.5M
Profitable Years	14
ROA	21.68
Roa5y	9.29
ROCE	32.94
ROE	37.53
Roe5y	16.95
ROIC	65.9
Roic5y	22.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.51%
Cagr1y	94.72%
Cagr3y	43.56%
Cagr5y	28.59%
Div CAGR3	35.72%
Div CAGR5	4.56%
EPS Growth	303.6
EPS Growth Q	611.7
EPS Growth Quarters	4
EPS Growth Years	2
EPS Growth3 Y	71.4
EPS Growth5 Y	35.11
FCF Growth	267.35%
FCF Growth Q	402.1%
FCF Growth3 Y	85.56%
FCF Growth5 Y	47.48%
OCF Growth	202.03%
OCF Growth Q	312.57%
OCF Growth10 Y	21.81%
OCF Growth3 Y	69.34%
OCF Growth5 Y	33.37%
Revenue Growth	94.29x
Revenue Growth Q	182.72x
Revenue Growth Quarters	1x
Revenue Growth Years	13x
Revenue Growth3 Y	28.08x
Revenue Growth5 Y	18.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.59
Assets	HKD 40.3B
Cash	HKD 21.8B
Current Assets	HKD 26.1B
Current Liabilities	HKD 5.1B
Debt	HKD 2.9B
Debt EBITDA	HKD 0.24
Debt Equity	HKD 0.09
Debt FCF	HKD 0.28
Equity	HKD 33.9B
Interest Coverage	137.3
Liabilities	HKD 6.5B
Long Term Assets	HKD 14.2B
Long Term Liabilities	HKD 1.4B
Net Cash	HKD 18.9B
Net Cash By Market Cap	HKD 33.83
Net Cash Growth	513.93%
Net Debt EBITDA	HKD -1.54
Net Debt Equity	HKD -0.56
Net Debt FCF	HKD -1.83
Tangible Book Value	HKD 23.7B
Tangible Book Value Per Share	HKD 9.47
WACC	7.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.13
Inventory Turnover	1.46
Net Working Capital	HKD 576.9M
Quick ratio	4.66
Working Capital	HKD 20.3B
Working Capital Turnover	HKD 1.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.04%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	HKD 0.25
Dividend Years	4
Dividend Yield	1.12%
Ex Div Date	2026-07-21
Last Dividend	HKD 0.25
Payout Frequency	Annual
Payout Ratio	6.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	171.68%
1Y total return	94.63%
200-day SMA	27.25
3Y total return	195.91%
50-day SMA	22.64
50-day SMA vs 200-day SMA	50under200
5Y total return	251.57%
All Time High	36.8
All Time High Change	-39.35%
All Time High Date	2025-09-10
All Time Low	4.72
All Time Low Change	372.88%
All Time Low Date	2022-03-15
ATR	1.36
Beta	0.56
Beta1y	1.11
Beta2y	0.44
Ch YTD	-7.69
High	22.84
High52	36.8
High52 Date	2025-09-10
High52ch	-39.35%
Low	22.08
Low52	10.94
Low52 Date	2025-05-12
Low52ch	104.02%
Ma50ch	-1.39%
Price vs 200-day SMA	-18.08%
RSI	46.07
RSI Monthly	58.68
RSI Weekly	45.05
Sharpe ratio	1.11x
Sortino ratio	2.13
Total Return	1.16%
Tr YTD	-7.69
Tr1m	-12.06%
Tr1w	-1.59%
Tr3m	-2.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 11.7B
Operating Income Growth	343.3
Operating Income Growth Q	729.2
Operating Income Growth3 Y	60.35
Operating Income Growth5 Y	35.06
Operating margin	59.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,852,796,591%
Net Borrowing	-1,116,876,820.7
Shares Insiders	5.79%
Shares Institutions	44.73%
Shares Out	2,500,652,236
Shares Qo Q	1.67%
Shares Yo Y	-0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 10.1B
Average Volume	33,940,516.75x
Bv Per Share	12.11
CAPEX	HKD -459.6M
Ch10y	147.2
Ch1m	-12.06
Ch1w	-1.59
Ch1y	93.08
Ch3m	-2.7
Ch3y	178.7
Ch5y	221.2
Ch6m	-22.55
Change	-2.7%
Change From Open	-2.28
Close	22.94
Days Gap	-0.44
Depreciation Amortization	584,954,877
Dollar Volume	366,684,187
Earnings Date	2026-08-21
EBIT	HKD 11.7B
EBITDA	HKD 12.2B
EPS	HKD 3.82
F Score	7
FCF	HKD 10.3B
FCF EV Yield	25.42x
FCF Per Share	HKD 4.12
Financing CF	2,619,899,182
Fiscal Year End	December
Founded	1,993
Goodwill	4,804,724,097.5
Graham Number	33.91621
Graham Upside	51.95
Income Tax	HKD 1.8B
Investing CF	-2,041,312,411
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Lynch Fair Value	HKD 94.37
Lynch Upside	322.8
Ma150	25.97
Ma150ch	-14.05%
Ma20	23.31
Ma20ch	-4.24%
Net CF	11,166,547,848
Next Earnings Date	2026-08-21
Open	22.84
P FCF Ratio	5.42
P OCF Ratio	5.19
Payment Date	2025-08-15
Position In Range	31.58
Ppne	6,192,690,376.2
Price Date	2026-05-08
Price EBITDA	HKD 4.56
Ptbv Ratio	2.36
Relative Volume	0.49x
Revenue	19,692,010,833x
SBC By Revenue	1.26x
Share Based Comp	248,348,089
Tax By Revenue	9.34x
Tax Rate	15.37%
Tr6m	-22.55%
Volume	16,428,503
Z Score	7.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/1530 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$0.25 annual per share

Payout ratio

+6.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+4.6%

0 consecutive years of growth

Total shareholder yield

+1.2%

Next ex-dividend date: 2026-07-21

Performance

HKG/1530 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/1530?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.7%

Share of float held by funds and institutions

Insider ownership

+5.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

HKG/1530 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.1

Neutral momentum band

Price vs 200-day MA

-18.1%

50/200-day relationship not available

Beta (5Y)

0.56

Less volatile than the market

Sharpe ratio

1.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/1530

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1530 stock rating?

hkg/1530 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1530 analysis?

The full report lives at /stocks/hkg/1530/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1530?

The latest report frames hkg/1530 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1530 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.